Peanut Oral Immunotherapy (OIT) for Children & Adults
Peanut Allergy
Investigating an oral immunotherapy protocol to safely desensitize patients with confirmed peanut allergy.
Age range
Ages 4–55
Duration
12–24 months
Compensation
Travel reimbursement provided
Eligibility Highlights
- Confirmed peanut allergy via skin prick or specific IgE
- Reactive to 100mg or less of peanut protein in a controlled challenge
- No history of severe asthma or eosinophilic GI disorder